The financial regulators issued an investor alert on April 10 on a set of 69 stock items related to COVID-19 including masks, test kits, vaccines and other sanitary and disease prevention items due to high fluctuations in prices and concerns over possible damages to investors.

Investors are advised to be aware of the possibility of incurring losses especially when investing in stocks for test kits or vaccines as their bullish prices tend to fall abruptly.

Investors should also watch out for unconfirmed information about the development schedule of vaccines or the effectiveness of similar medicines circulating on the stock market bulletin boards, the internet or through text messaging system.

The financial authorities will strengthen the market monitoring and supervisory functions to prevent unfair trading practices in the capital markets, such as the spread of false information and/or exaggerated announcement of business plans.

* Please refer to the attached PDF for details.